Under hypoxic conditions, loss of GLUT4 can critically repress breast cancer cell proliferation and impair cell viability, verifying the feasibility of inhibiting GLUT4 pharmacologically to induce in vivo metabolic reprogramming in cancer models (38). The gene discussed is SLC2A4; the disease is breast cancer.